期刊文献+

吉林省1772株结核分枝杆菌卡那霉素耐药状况分析

Analysis of kanamycin resistance in 1772 mycobacterium tuberculosis of Jilin province
原文传递
导出
摘要 目的完善吉林省结核病耐药谱分析,采用国际通用的比例法获得吉林省结核病卡那霉素耐药资料,评价本省结核治疗临床常用药效果。方法按照国际通用标准,采用100%诊断中心抽样方法,对分离培养阳性菌株进行菌型鉴定及卡那霉素(KM)药物敏感性测试。结果收集到可供分析的结核分枝杆菌分离株1 772株,卡那霉素的耐药率为4.91%;其中来自初治涂阳肺结核患者的菌株为1 175株(66.14%),卡那霉素耐药率为3.74%;来自复治涂阳肺结核患者菌株597株(33.69%),卡那霉素耐药率为7.20%。结论吉林省结核病卡那霉素初、复治耐药率均高于全国平均水平,应加强二线抗结核药物的规范、合理使用。 Objective To surveillance network to improve drug resistance of tuberculosis in Jilin province, apply international comparability of TB resistant to kanamycin information to evaluate the effect of the current TB control strategies. Methods According to WHO / IUATLD standard ,sampling method using 100% of diagnostic centers for culturepositive isolates were separated bacterial type identification and kanamycin ( KM ) drug susceptibility testing. Results 1 772 strains were collected and isolaled for analysis of mycobacterium tuberculosis, kanamycin resistance rate was 4. 91% , of which isolated from the smear positive TB patients the early of 1 175 (66. 14% ), kanamycin resistance rate of 3.74% ; 597 strains (33.69%) were isolated from retreatment smear - positive tuberculosis patients, kanamycin resistance was 7.20%. Conclusion Tuberculosis resistant to kanamycin of Jilin province is higher than that of national average level. It' s suggested to further strengthen the prevention and treatment of drug -resistant TB.
出处 《中国卫生工程学》 CAS 2014年第5期393-394,共2页 Chinese Journal of Public Health Engineering
关键词 结核分枝杆菌 卡那霉素 耐药 Mycobacterium tuberculosis Kanamycin Drug resistance
  • 相关文献

参考文献5

  • 1World Health Organization, International Union Against Tubercu losis and Lung Diseases. Guidelines for surveillance of drug resist ance in tuberculosis[ R ]. Geneva : W HO, 1997.
  • 2中国防痨协会基础专业委员会.结核病诊断实验室检验规程[M].北京:中国教育出版社,2006.13-16.
  • 3肖东楼,许绍发,王黎霞,等,2007-2008全国结核病耐药基线调查报告[M].北京:人民卫生出版社,2010:27-28.
  • 4胡远莲,何广学,刘志敏,郑建礼,邢超.我国二线抗结核药物使用现状调查研究[J].中国防痨杂志,2010,32(3):123-128. 被引量:17
  • 5屠德华.迎接结核病控制的创新时代[J].中国防痨杂志,2010,32(3):121-122. 被引量:44

二级参考文献11

  • 1张国龙,杜长梅,苍泽卓也,池田雄史,王伟,石瑞如.中日合作对河南省结核菌二线药物耐药监测研究[J].医药论坛杂志,2005,26(19):14-16. 被引量:15
  • 2李晓红,虞德才,左改珍,陈义芬,张炳新,鲁朝辉.1132例住院患者抗菌药物使用率横断面调查[J].中华医院感染学杂志,2006,16(6):684-686. 被引量:44
  • 3Global tuberculsis control: epidemiology, strategy, financing: WHO report 2009. Genera WHO/HTM/TB 2009: 411.
  • 4World Health Organization. Anti-tuberculosis drnug resistance in the world (report No 4). WHO/HTM/TB 2008:394.
  • 5The Global Plan to stop TB. 2006--2015. Genevs,WHO/HTM/ STB/2006 : 35.
  • 6中国疾病预防控制中心结核病预防控制中心(编译).结核病控制新技术,新技术采纳引进和实施框架.WHO/HTM/STB/2007.40.
  • 7刘小秋 姜世闻 杜莹 王晓梅 王黎霞.结核病专科医院对住院肺结核患者的诊断与治疗现状分析.中国防痨杂志,2007,29:153-153.
  • 8N. Sarita Shah, Robert Pratt, Lori Armstrong, Valerie Robison, Kenneth G. Castro, J. Peter Cegielski. Extensively Drug- Resistant Tuberculosis in the United States, 1993--2007[J]. JAMA, 2008, 300(18):2153--2160.
  • 9Ginsburg AS, Grosset JH, Bishai WR. Fluoroquinolones, tuberculosis, and resistance[J]. THE LANCET Infectious Disease. 2003 , 3 : 432--439.
  • 10徐京杭,于岩岩.发热患者院前抗菌药物使用情况的调查分析[J].中国实用内科杂志,2007,27(21):1692-1694. 被引量:10

共引文献286

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部